Investing.com — Progyny (NASDAQ: ), a company specializing in the management of fertility benefits, reported a 5.8% increase in its premarket value after showing that the results of the fourth This quarter was slightly above the forecast given earlier.

Progyny’s CEO, Pete Anevski, expressed satisfaction with the company’s performance in the fourth quarter. He stated that member activity remains a positive trend compared to their previous estimates.

In the company’s official statement, Anevski further revealed that they now expect fourth quarter results for revenue, net income, and adjusted Ebitda to exceed the ranges they previously provided in November .

This article was created with the support of AI and reviewed by an editor. For more information see our T&C.